Bio Korea 2022 May 11 - 13th, 2022 | Coex, Seoul

Join us at the BIO KOREA conference May 11th-13th. Stop by our exhibit at the Australian National Pavilion, booth M13.

Will you be attending this year? George Clinical’s Chief Executive Officer, James Cheong, will be presenting online Thursday, May 12th 2:30-3:00PM (KST) / 3:30-4:00PM (AEST). Representatives of the George Clinical team, Elisabeth Yunarko and MiSoon Seo will both be in attendance to answer questions and discuss George Clinical’s expertise as a full-service CRO which includes:

  • Expertise in Early Phase studies in Australia and Asia-Pacific
  • Scientific expertise and extensive KOL networks in a broad range of therapeutic areas
  • Deep expertise in Oncology and Renal trials
  • Accreditation from the Australian Office of Gene Regulators (OGTR)

George Clinical provides a full scope of CRO services with the flexibility to provide single services as well as a full scope trial management solution to suit the requirements of clients ranging from biotech start-ups, pharmaceutical, medical devices as well as academic institutions. We look forward to meeting with Korean companies looking to conduct clinical trials in Australia and beyond.

If you would like to set up a time to meet or learn more about how George Clinical can help you with your upcoming trial, please email Elisabeth Yunarko at [email protected].

Since 2006, BIO KOREA has served as a business platform for international biohealth companies. Sponsored by the Ministry of Health and Welfare, BIO KOREA is a place in which experts and world-class scholars from the biohealth industry will participate to obtain, exchange, and discuss diverse affairs, through exhibition, business forum, and conference. This year’s conference will be held both online and onsite with discussions around the latest industrial technology trends.

George Clinical's Leadership in Attendance

Mary Gunn, PhD, MBA, MA, LLM

  • Chief Executive Officer

With over three decades of experience, Dr Gunn has held pivotal roles in leading biotech firms and academic institutions including Pfizer, Crucell (Johnson & Johnson), Becton Dickson, Clintec (IQVIA), ICON, and Health Decisions (Premier Research). She is a corporate strategy expert with extensive experience in life science corporate development, strategic partnerships, co-development, licensing partnerships, M&A and post-merger integrations. She is renowned for her extensive contributions to medical research, innovative drug development, contract research and clinical trials, and has spearheaded the development of several FDA-approved drugs, particularly in the CNS and vaccines domains. She is passionate about market access to innovation.

Event Location

Coex, Seoul
Coex, Seoul

Attending this event?

Meet with George Clinical! Contact us to schedule a time now.

    I agree to the handling of my personal information in accordance with the George Clinical privacy policy.

    Please input this code: captcha

    Add George Clinical to your network